FDA Approves Cervical Injections To Treat ALS In Spinal Stem Cell Trial

Neuralstem recently announced its updated findings in a Phase I safety trial involving the use of spinal cord stem cells to treat amyotrophic lateral sclerosis (ALS or Lou Gehrigs disease). The Food and Drug Administration (FDA) has granted approval for Neuralstems trial to begin transplanting patients in the cervical back region.

Grant Will Advance Wireless Technology For People With Disabilities

A 5-year grant from the US Department of Educations National Institute on Disability and Rehabilitation Research (NIDRR) was recently awarded to the Shepherd Center and the Georgia Institute of Technology. The award will support the continuation of research and the development of wireless technology at the Rehabilitation Engineering Research Center (RERC) for people with disabilites.

Inclusive Forum To Share Strength Through New Abilities

In recognition of October, National Disability Employment Awareness Month, the Kessler Foundation is encouraging people, particularly those with disabilities, to share the limitations that they have overcome and the new abilities they have developed as a result, on the foundations Facebook page.